Shingrix Shingles Vaccine 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single Dose Vial Kit 10 Doses
- SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older \n
- SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox) \n
- SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles) \n
- A single dose after reconstitution is 0.5 mL \n
- Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
- Brand:
- Shingrix
- Strength:
- 50 mcg / 0.5 ml
- Dosage form:
- injection
- Mckesson #:
- 1081079
- Type:
- intramuscular
- Container type:
- single dose vial kit
- Manufacturer #:
- 58160082311
- Application:
- shingles vaccine
- UNSPSC:
- 51201600
- NDC number:
- 58160082311
- Product dating:
- mckesson acceptable dating: we will ship >= 180 days
- Volume:
- 10 doses
- Refno:
- 3739638
- Manufacturer:
- Glaxo Smith Kline
- Patient type:
- 50 years of age and older
- Generic drug code:
- 43989
- Storage requirements:
- requires refrigeration
- Generic drug name:
- zoster vaccine recombinant adjuvanted